Deals Allergan bid may be last big pharma deal for some time for Valeant Add to ...

SHARE

Replay
BNN Video |
Show Description
Valeant & activist investor Bill Ackman are bidding for U.S. drug company Allergan. If the deal goes through Valeant will take on about $16B in new debt which could put the brakes on future deals for Valeant.

More from this section

Most Popular

Editor's Picks

Globe Shows »

Careers
Put your best foot forward with our expert advice